446 related articles for article (PubMed ID: 16813712)
1. [Relationship between body mass index and leptin levels in children treated for acute lymphoblastic leukemia during and after maintenance therapy].
Muszyńska-Rosłan K; Krawczuk-Rybak M; Topczewska M; Sawicka-Zukowska M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):91-5. PubMed ID: 16813712
[TBL] [Abstract][Full Text] [Related]
2. [Effect of anticancer treatment on leptin level, fat body mass (FM) and lean body mass (LBM)].
Krawczyk-Rybak M; Muszyńska-Rosłan K; Konstantynowicz J; Solarz E; Wołczynski S; Protas P
Med Wieku Rozwoj; 2004; 8(2 Pt 1):297-307. PubMed ID: 15738606
[TBL] [Abstract][Full Text] [Related]
3. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
5. [Growth and puberty in children after treatment of acute lymphoblastic leukemia].
Misíková Z; Foltinová A; Cáp J; Kostálová L; Vargová K
Cas Lek Cesk; 1997 Jan; 136(2):54-6. PubMed ID: 9147855
[TBL] [Abstract][Full Text] [Related]
6. Serum leptin levels during childhood and adolescence: relationship with age, sex, adiposity and puberty.
Kirel B; Doğruel N; Akgün N; Kiliç FS; Tekin N; Uçar B
Turk J Pediatr; 1999; 41(4):447-55. PubMed ID: 10770112
[TBL] [Abstract][Full Text] [Related]
7. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
Razzouk BI; Rose SR; Hongeng S; Wallace D; Smeltzer MP; Zacher M; Pui CH; Hudson MM
J Clin Oncol; 2007 Apr; 25(10):1183-9. PubMed ID: 17401007
[TBL] [Abstract][Full Text] [Related]
8. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children.
Krawczuk-Rybak M; Muszyńska-Rosłan K; Kitszel A; Sawicka-Zukowska M; Wołczyński S
Rocz Akad Med Bialymst; 2005; 50():208-11. PubMed ID: 16358968
[TBL] [Abstract][Full Text] [Related]
9. Determinants and impact of sleep duration in children and adolescents: data of the Kiel Obesity Prevention Study.
Hitze B; Bosy-Westphal A; Bielfeldt F; Settler U; Plachta-Danielzik S; Pfeuffer M; Schrezenmeir J; Mönig H; Müller MJ
Eur J Clin Nutr; 2009 Jun; 63(6):739-46. PubMed ID: 18665183
[TBL] [Abstract][Full Text] [Related]
10. Incidence of obesity does not appear to be increased after treatment of acute lymphoblastic leukemia in Brazilian children: role of leptin, insulin, and IGF-1.
Papadia C; Naves LA; Costa SS; Vaz JA; Domingues L; Casulari LA
Horm Res; 2007; 68(4):164-70. PubMed ID: 17356293
[TBL] [Abstract][Full Text] [Related]
11. Influence of treatment modalities on body weight in acute lymphoblastic leukemia.
Groot-Loonen JJ; Otten BJ; van't Hof MA; Lippens RJ; Stoelinga GB
Med Pediatr Oncol; 1996 Aug; 27(2):92-7. PubMed ID: 8649326
[TBL] [Abstract][Full Text] [Related]
12. Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.
Dalton VK; Rue M; Silverman LB; Gelber RD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin M; Tarbell NJ; Sallan SE; Cohen LE
J Clin Oncol; 2003 Aug; 21(15):2953-60. PubMed ID: 12885815
[TBL] [Abstract][Full Text] [Related]
13. Leptin assessment in acute lymphocytic leukemia survivors: role of cranial radiotherapy?
Siviero-Miachon AA; Spinola-Castro AM; Tosta-Hernandez PD; de Martino Lee ML; Petrilli AS
J Pediatr Hematol Oncol; 2007 Nov; 29(11):776-82. PubMed ID: 17984698
[TBL] [Abstract][Full Text] [Related]
14. Time course and determinants of leptin decline during weight loss in obese boys and girls.
Holm JC; Gamborg M; Kaas-Ibsen K; Gammeltoft S; Ward L; Heitmann BL; Sørensen TI
Int J Pediatr Obes; 2007; 2(1):2-10. PubMed ID: 17763005
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia.
Vilela MI; Viana MB
Pediatr Blood Cancer; 2007 Jan; 48(1):86-92. PubMed ID: 16700045
[TBL] [Abstract][Full Text] [Related]
16. Final height and weight of long-term survivors of childhood malignancies.
Müller HL; Klinkhammer-Schalke M; Kühl J
Exp Clin Endocrinol Diabetes; 1998; 106(2):135-9. PubMed ID: 9628245
[TBL] [Abstract][Full Text] [Related]
17. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
18. [Study on the effects of leptin on puberty development in children].
Sun C; Yu C; Wang S
Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):293-6. PubMed ID: 11769624
[TBL] [Abstract][Full Text] [Related]
19. Leptin and estradiol as related to change in pubertal status and body weight.
Larmore KA; O'Connor D; Sherman TI; Funanage VL; Hassink SG; Klein KO
Med Sci Monit; 2002 Mar; 8(3):CR206-10. PubMed ID: 11889458
[TBL] [Abstract][Full Text] [Related]
20. Body composition and concentrations of leptin, neuropeptide Y, beta-endorphin, growth hormone, insulin-like growth factor-I and insulin at menarche in girls with constitutional delay of puberty.
Błogowska A; Krzyzanowska-Swiniarska B; Zielińska D; Rzepka-Górska I
Gynecol Endocrinol; 2006 May; 22(5):274-8. PubMed ID: 16785149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
